Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8633194 | CHATTEM SANOFI | Pharmaceutical composition of piperazine derivatives |
Oct, 2027
(4 years from now) |
Market Authorisation Date: 31 January, 2017
Treatment: NA
Dosage: SOLUTION;ORAL
3
European Union
1
South Africa
1
Austria
1
Mexico
1
Australia
1
Hong Kong
1
Norway
1
Germany
1
United States
1
Argentina
1
Brazil
1
Portugal
1
Cyprus
1
Malaysia
1
Spain
1
Peru
1
Korea, Republic of
1
Poland
1
Taiwan, Province of China
1
China
1
Japan
1
EA
1
Canada
1
New Zealand
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic